Literature DB >> 22524839

Endo-sulfatase Sulf-1 protein expression is down-regulated in gastric cancer.

Gopisetty Gopal1, Sundersingh Shirley, Uthandaraman Mahalinga Raja, Thangarajan Rajkumar.   

Abstract

In our recent report on gene expression in gastric cancer we identified the endo-sulfatase Sulf-1 gene to be up-regulated in gastric tumors relative to apparently normal (AN), and paired normal (PN) gastric tissue samples. In the present report we investigate the protein expression levels of Sulf-1 gene in gastric tumors, AN and PN samples using tissue microarray (TMA) and immunohistochemistry. Expression data was collected from two sets of TMA's containing replicate sections of tissue samples. Scoring data from TMA set-1 revealed a significant difference in Sulf-1 immunoreactivity between tumors and "normals" (PN and AN) (p-value = 0.001928). Also, Sulf-1 expression in tumors was also significantly different from either PN (p-value = 0.019) or AN (p-value = 0.006) samples. Similar results were obtained from analysis of scoring data from the second set of arrays. Comparison of mRNA expression and protein expression in gastric tumor tissues revealed that in 6/20 (30%) tumor samples showed up-regulated protein expression concordant with over-expression of mRNA. However, a discord with mRNA being over-expressed relative to down regulated protein expression was observed in majority 14/20 (70%) of tumor samples. Our study indicates down regulation of Sulf-1 protein expression in gastric tumors relative to PN and AN samples which is discordant with mRNA over-expression seen in tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524839     DOI: 10.7314/apjcp.2012.13.2.641

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin.

Authors:  Salma Abdi Mahmoud; Mohammed Mohammed Ibrahim; Ahmed Hago Musa; Yuhong Huang; Jun Zhang; Jingwen Wang; Yuanyi Wei; Li Wang; Shunting Zhou; Boyi Xin; Wei Xuan; Jianwu Tang
Journal:  J Cell Commun Signal       Date:  2017-12-23       Impact factor: 5.782

2.  Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett's Esophagus.

Authors:  Xiaojuan Zhao; Ruben Y Gabriëls; Wouter T R Hooghiemstra; Marjory Koller; Gert Jan Meersma; Manon Buist-Homan; Lydia Visser; Dominic J Robinson; Anna Tenditnaya; Dimitris Gorpas; Vasilis Ntziachristos; Arend Karrenbeld; Gursah Kats-Ugurlu; Rudolf S N Fehrmann; Wouter B Nagengast
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 3.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

4.  Gastric Cancer Heterogeneity and Clinical Outcomes.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Md Hafiz Uddin; Maria Diab; Asfar S Azmi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  GPR160 is a potential biomarker associated with prostate cancer.

Authors:  Wanjing Guo; Junyu Zhang; Yan Zhou; Caihong Zhou; Yunjie Yang; Zhaotong Cong; Jibin Dong; Dehua Yang; Bo Dai; Ming-Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.